Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy

Ho, T. T., Cadena, J., Childs, L. M., Gonzalez-Velez, M., Lewis, J. S.·2012·Journal of Antimicrobial Chemotherapy

Abstract

BACKGROUND: One of the newest methicillin-resistant Staphylococcus aureus (MRSA) antibiotics to receive FDA approval is ceftaroline fosamil, a member of a new subclass of cephalosporins with unique activity against MRSA. However, ceftaroline is currently only FDA approved for complicated skin/soft tissue infections and community-acquired pneumonia; there are currently no clinical data regarding its use in MRSA bacteraemia and endocarditis. We report a series of six patients in which ceftaroline was utilized as salvage monotherapy in persistent MRSA bacteraemia or endocarditis. METHODS: Using pharmacy records, 11 ceftaroline-treated patients were identified between January 2011 and November 2011 at University Health System and the South Texas Veterans Health Care System in San Antonio, TX, USA. All cases were reviewed and six patients received ceftaroline therapy for MRSA bacteraemia or endocarditis due to persistent or recurrent bacteraemia while on standard antibiotics (vancomycin or daptomycin). RESULTS: All six patients experienced rapid clearance of their bacteraemia after starting ceftaroline. In the case of endocarditis for which the patient subsequently developed heart failure and required valve replacement, there was no evidence of growth from cultures taken from the excised valve, suggesting sterilization within 13 days of starting ceftaroline. CONCLUSIONS: Ceftaroline exhibits potent anti-MRSA activity in both in vitro and animal studies, including rabbit endocarditis models; however, the lack of clinical data has limited its use in bacteraemia and endovascular infections in humans. We hope that this series serves as an initial stepping stone for further evaluation of this compound for more invasive infections due to MRSA.

Overview

Integrity signals

Registry

Crossref · 10.1093/jac/dks006

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 8 references

Cited by

See all 130

Metadata

Authors
Ho, T. T., Cadena, J., Childs, L. M., Gonzalez-Velez, M., & Lewis, J. S.
Affiliations
  • The University of Texas at San Antonio Health Science Center (US)
  • Audie L. Murphy Memorial VA Hospital (US)
Corresponding author
Lewis, J. S.
Venue
Journal of Antimicrobial Chemotherapy
Published
2012-02-06
Volume
67
Issue
5
Pages
1267-1270
ISSN
  • 0305-7453 (ISSN-L)
  • 1460-2091
OpenAlex
W2160238480
Cited by
130
References
8
Citations by year
2026: 2 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 7 · 2019: 10 · 2018: 7 · 2017: 20 · 2016: 16 · 2015: 12 · 2014: 19 · 2013: 18 · 2012: 3
FWCI
11.48
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Antimicrobial Chemotherapy (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Keywords
methicillin-resistant Staphylococcus aureus, ceftaroline fosamil, MRSA bacteremia, infective endocarditis, salvage therapy, persistent bacteraemia, recurrent bacteraemia, vancomycin, daptomycin, heart failure, valve replacement, cephalosporins
MeSH terms
Ceftaroline, Adult, Anti-Bacterial Agents, Cephalosporins, Endocarditis, Bacterial, Female, Humans, Male, Middle Aged, Staphylococcal Infections, Texas, Bacteremia, Salvage Therapy, Treatment Outcome, Methicillin-Resistant Staphylococcus aureus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy. https://app.cochat.ai/papers/10.1093/jac/dks006
The paper
Ho, T. T., Cadena, J., Childs, L. M., Gonzalez-Velez, M., & Lewis, J. S. (2012). Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dks006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.